Slides on Precision Management of Late Endocrine Effects in Cancer Survivors

Downloadable slideset from Sagar Lonial, MD and Kathryn Maples, PharmD, BCOP on treatment options for patients with R/R myeloma, from Clinical Care Options (CCO).

Sagar Lonial, MD Kathryn Maples, PharmD, BCOP Released: May 4, 2021

Expert insight from Arjun Balar, MD, on choosing optimal therapy for patients with advanced urothelial cancer after chemo and IO, from Clinical Care Options (CCO)

Arjun Balar, MD Kaitlynn Francese, MSN, RN, OCN Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: May 4, 2021 Expired: May 3, 2022

Slides from Arjun Balar, MD on the role of antibody-drug conjugates in early stage urothelial cancer, from Clinical Care Options (CCO)

Arjun Balar, MD Released: May 4, 2021

Jubilee Brown, MD, and Ursula Matulonis, MD, discuss current challenges in the management of endometrial and ovarian cancer, from Clinical Care Options (CCO)

Jubilee Brown, MD Ursula Matulonis, MD Released: May 3, 2021